MetaCap

Gelteq Limited Company Profile

NASDAQ: GELSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5488-0.0111 (-1.98%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Pre-market: 0.526 -4.15%

Gelteq at a glance

Gelteq Limited (NASDAQ: GELS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Clayton, VIC, Australia. Gelteq is led by Mr. Nathan Jacob Givoni and employs about 7 people. The company's shares have traded publicly since 2024.

At a market capitalization of $5.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001920092, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Gelteq do?

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Business description based on the company's public filings.

Company information

Legal name
Gelteq Limited
Ticker
NASDAQ: GELS
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Nathan Jacob Givoni
Employees
7
Headquarters
Monash Innovation Labs, Clayton, VIC, Australia
Phone
61 3 9087 3990
Website
gelteq.com
IPO year
2024
SEC CIK
0001920092

Companies similar to Gelteq

GELS peer companies
CompanyPrice% ChgMarket capCompare
IMNNImunon Inc.1.07-4.46%$6.00Mvs GELS
KALAKALA BIO Inc.0.2966-17.61%$5.74Mvs GELS
CANFCan-Fite Biopharma Ltd ADR2.00-4.76%$6.06Mvs GELS
PULMPulmatrix Inc.1.53+2.49%$5.58Mvs GELS
ADXNAddex Therapeutics Ltd ADR3.18+6.81%$5.57Mvs GELS
ENLVEnlivex Ltd.0.277-10.85%$5.51Mvs GELS
BGMSBio Green Med Solution Inc.0.821-3.41%$5.44Mvs GELS
SCNXScienture Holdings Inc.3.86-6.54%$6.34Mvs GELS

Related